Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multidrug resistance: a role for cholesterol efflux pathways?

M Liscovitch1, Y Lavie

  • 1Dept of Biological Regulation, Weizmann Institute of Science, 76100, Rehovot, Israel. moti.liscovitch@weizmann.ac.il

Trends in Biochemical Sciences
|November 21, 2000
PubMed
Summary

Multidrug resistance (MDR) in cancer cells involves increased caveolin and caveolae, potentially aiding drug export. This adaptation alters cholesterol homeostasis and reduces cancer cell transformation features.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upregulation of caveolin in multidrug resistant cancer cells: functional implications.

Advanced drug delivery reviews·2001
Same author

Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.

Anticancer research·2001
Same author

Changes in lipid and protein constituents of rafts and caveolae in multidrug resistant cancer cells and their functional consequences.

Glycoconjugate journal·2001
Same author

Changes in phospholipase D isoform activity and expression in multidrug-resistant human cancer cells.

International journal of cancer·2000
Same author

Phospholipase D2: functional interaction with caveolin in low-density membrane microdomains.

FEBS letters·2000
Same author

Phospholipase D: molecular and cell biology of a novel gene family.

The Biochemical journal·2000

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cancer Research

Background:

  • Multidrug resistance (MDR) significantly reduces chemotherapy effectiveness in cancer treatment.
  • While drug efflux transporters are known, other cellular adaptations are crucial for MDR.
  • Increased cell surface caveolae and caveolin expression are observed in MDR cancer cells.

Purpose of the Study:

  • To investigate the role of caveolin and caveolae in multidrug resistance.
  • To explore the connection between caveolin-dependent cholesterol efflux and drug transport in MDR cells.
  • To understand how caveolin upregulation impacts the phenotype and cholesterol homeostasis of MDR cancer cells.

Main Methods:

  • Analysis of caveolae and caveolin expression in multidrug-resistant cancer cells.

Related Experiment Videos

  • Investigation of cholesterol efflux pathways in relation to MDR.
  • Assessment of phenotypic changes and cholesterol homeostasis in MDR cells with altered caveolin levels.

    • Main Results:

    • Multidrug-resistant cancer cells exhibit dramatically increased cell surface caveolae and caveolin expression.
    • Upregulation of caveolin correlates with enhanced caveolin-dependent cholesterol efflux pathways.
    • These pathways may facilitate intracellular drug transport to the plasma membrane for extrusion by efflux ATPases.
    • Caveolin upregulation leads to altered cholesterol homeostasis and a loss of transformed cell phenotype in MDR cells.

    Conclusions:

    • Caveolin and caveolae play a significant role in the development of multidrug resistance in cancer.
    • Caveolin-mediated cholesterol transport pathways are implicated in the mechanism of drug extrusion.
    • Targeting caveolin or associated pathways may offer novel strategies to overcome MDR and re-sensitize cancer cells to chemotherapy.